Factors Related to the Severity of Dengue Infection in Adult Patients Treated at Sanjiwani Regional General Hospital
DOI:
https://doi.org/10.22225/ijbstm.3.1.2026.1-6Keywords:
dengue fever, dengue hemorrhagic fever, dengue virusAbstract
Dengue infection remains a major global health problem. This study aimed to determine factors associated with the severity of dengue infection among adult patients treated at Sanjiwani Gianyar Regional General Hospital in 2023. An analytical observational study with a cross-sectional design was conducted using consecutive sampling. A total of 100 adult patients with confirmed dengue infection were included. Severity was classified as Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) based on WHO criteria. Chi-square analysis and crude odds ratio (OR) estimation were performed. Age >60 years was significantly associated with severe dengue (OR = 2.94; 95% CI: 1.25–6.92; p=0.014). Female gender was also associated with higher odds of severe dengue compared to males (OR = 2.33; 95% CI: 1.05–5.15; p=0.039). Secondary infection status showed the strongest association with severity (OR = 5.40; 95% CI: 2.24–13.04; p=0.001). In conclusion, age, gender, and infection status were significantly associated with dengue severity. These findings may assist clinicians in identifying patients who require closer clinical monitoring.
References
Dash MK, Samal S, Rout S, Behera CK, Sahu MC, Das B. Immunomodulation in dengue: towards deciphering dengue severity markers. Cell Commun Signal. 2024;22(1). doi:10.1186/s12964-024-01779-4
2. Deng J, et al. Global, regional, and national burden of dengue infection in children and adolescents: an analysis of the Global Burden of Disease Study 2021. eClinicalMedicine. 2024;78:102943.
3. Downs WG. Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control. 2017.
4. Flipse J, Diosa-Toro MA, Hoornweg TE, van de Pol DPI, Urcuqui-Inchima S, Smit JM. Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages. Sci Rep. 2016;6:29201. doi:10.1038/srep29201
5. Hökerberg YHM, Kohn F, Souza TS de, Passos SRL. Clinical profile of dengue in the elderly using surveillance data from two epidemics. Rev Soc Bras Med Trop. 2022;55. doi:10.1590/0037-8682-0290-2021
6. Imad HA, Phumratanaprapin W, Phonrat B, et al. Cytokine expression in dengue fever and dengue hemorrhagic fever patients with bleeding and severe hepatitis. Am J Trop Med Hyg. 2020;102(5):943-950. doi:10.4269/ajtmh.19-0487
7. Khairunisa SQ, Masyeni S, Witaningrum AM, et al. Genotypic characterization of human immunodeficiency virus type 1 isolated in Bali, Indonesia in 2016. HIV AIDS Rev. 2018;17(2):81-90.
8. Liu LT, Huang SY, Lin CH, et al. The epidemiology and identification of risk factors associated with severe dengue during the 2023 dengue outbreak in Kaohsiung City, Taiwan. Travel Med Infect Dis. 2025;65:102852. doi:10.1016/j.tmaid.2025.102852
9. Ma’roef CN, Dhenni R, Megawati D, et al. Japanese encephalitis virus infection in non-encephalitic acute febrile illness patients. PLoS Negl Trop Dis. 2020;14(7):1-13. doi:10.1371/journal.pntd.0008454
10. Masyeni S, Yohan B, Somia IKA, Myint KSA, Sasmono RT. Dengue infection in international travellers visiting Bali, Indonesia. J Travel Med. 2018;25(1). doi:10.1093/jtm/tay061
11. Masyeni S, Fatawy RM, Paramasatiari AAAL, et al. Dengue seroprevalence study in Bali. PLoS One. 2023;18(7):e0271939. doi:10.1371/journal.pone.0271939
12. Masyeni S, Kuntaman K, Aryati A, et al. The role of SOCS, TLR-3 and NF?B on cytokine production during dengue virus infection. Narra J. 2023;3(2). doi:10.52225/narra.v3i2.167
13. Masyeni S, Wardhana IMW, Nainu F. Cytokine profiles in dengue fever and dengue hemorrhagic fever: A study from Indonesia. Narra J. 2024;4(1):e309. doi:10.52225/narra.v4i1.309
14. Nanda JD, Jung CJ, Satria RD, et al. Serum IL-18 is a potential biomarker for predicting severe dengue progression. J Immunol Res. 2021;2021:1-15. doi:10.1155/2021/7652569
15. Paraná VC, Feitosa CA, da Silva GCS, Gois LL, Santos LA. Risk factors associated with severe dengue in Latin America: A systematic review and meta-analysis. Trop Med Int Health. 2024;29(3):173-191. doi:10.1111/tmi.13968
16. Sasmono RT, Masyeni S, Hayati RF, et al. Dengue dynamics in Bali: Serotype shifts, genotype replacement and multiple virus lineage circulation in the last 10 years. Trop Med Int Health. 2025;30(4):303-313. doi:10.1111/tmi.14095
17. Shahid Ansari M, Jain D, Harikumar H, et al. Identification of predictors and model for predicting prolonged length of stay in dengue patients. Health Care Manag Sci. 2021;24(4):786-798. doi:10.1007/s10729-021-09571-3
18. Valero N, Mosquera J, Levy A, Añez G, Marcucci R, Alvarez-Mon M. Differential induction of cytokines by neonatal, adult, and elderly monocyte/macrophages infected with dengue virus. Viral Immunol. 2014;27(4):151-159. doi:10.1089/vim.2013.0123
19. Witari NPD, Masyeni S, Rusni NW, Sumadewi KT, Pratiwi AE, Asih PB. A case of imported Plasmodium falciparum chloroquine and sulfadoxine-pyrimethamine sensitive in a Finland male presentation. IOP Conf Ser Mater Sci Eng. 2018;434:012145. doi:10.1088/1757-899X/434/1/012145
20. Yuan K, Chen Y, Zhong M, Lin Y, Liu L. Risk and predictive factors for severe dengue infection: A systematic review and meta-analysis. PLoS One. 2022;17(4):e0267186. doi:10.1371/journal.pone.0267186
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ida Bagus Made Agastya Pranata, Saraswati Laksmi Dewi, Putu Aryagiri Prebawa, Komang Trisna Sumadewi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
